**
Research conducted by the University of Edinburgh reveals that individuals in the UK suffering from hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS) endure astonishingly long waits—up to 21 years—before receiving a formal diagnosis. This delay often exacerbates a range of debilitating symptoms, from chronic pain to joint dislocations. The findings underscore a critical gap in awareness and understanding of these conditions within the healthcare system.
Alarmingly Prolonged Diagnostic Delays
The comprehensive study, which surveyed over 2,000 individuals, is the largest of its kind and highlights the pressing need for improved recognition of hypermobility disorders among healthcare professionals. The symptoms associated with HSD and hEDS—affecting connective tissue throughout the body—can include not only joint hypermobility but also chronic pain, fatigue, and a variety of neurological, gastrointestinal, and psychological issues.
Prominent figures like writer and actor Lena Dunham have shared their personal experiences with hEDS, illustrating the common struggle of misattributing serious health concerns to mere ‘quirks’ of the body. In her recent book, *Famesick*, Dunham reflects on her years of suffering with symptoms that were never connected into a cohesive diagnosis, emphasizing how the healthcare system often overlooks the pain experienced by women and girls.
Fragmented Healthcare Experience
The research indicates that patients with HSD and hEDS frequently encounter fragmented healthcare services, which can severely affect their mental well-being, education, and employment prospects. The online survey, conducted between September 2023 and January 2024, revealed that nearly half of respondents were unemployed (46%) and received disability-related benefits (48%). Moreover, a significant 56% reported interruptions in their education.
The impact of chronic pain is stark: 84% of respondents reported enduring this condition, while 74% experienced partially dislocated joints, and 66% had gastrointestinal symptoms. Mental health concerns are equally pervasive, with 71% of participants reporting anxiety, 63% experiencing depression, and 53% suffering from migraines. Kathryn Berg, trial and data manager at the Institute of Genetics and Cancer, emphasised the critical need for multidisciplinary care pathways that acknowledge the complex nature of these disorders.
Geographic Disparities in Diagnosis
Geographic disparities in diagnostic experiences were also evident in the study. Patients from Wales faced the longest diagnostic delays, averaging 21.7 years from symptom onset to diagnosis. Northern Ireland followed closely with an average of 21.1 years, while Scotland and England had marginally shorter waiting periods of 19.5 and 19 years, respectively.
A concerning trend emerged, with many patients travelling across the UK to seek a diagnosis. Over a third of respondents from Wales and Northern Ireland reported needing to leave their regions for proper assessment, while 17% of those in Scotland did the same. In contrast, the majority of individuals in England (98%) received their diagnoses within their own country.
Response from Government and Medical Institutions
In light of these findings, a spokesperson for the Welsh government acknowledged the lengthy and complex journeys that patients face to obtain an accurate diagnosis. The government is pursuing clinical endorsement for a draft community health pathway intended to provide more consistent care and better access to specialists across Wales.
In response to the alarming diagnostic delays, a UK government spokesperson stated, “People living with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders deserve to have their symptoms recognised and taken seriously.” They highlighted the development of a toolkit by the Royal College of General Practitioners, in collaboration with EDS Support UK, aimed at equipping clinicians with the knowledge required to recognise and manage these complex conditions effectively.
Why it Matters
The findings from this study reveal a critical need for systemic reform in the recognition and treatment of hypermobility disorders. The lengthy diagnostic journeys faced by patients not only exacerbate their physical suffering but also significantly impact their mental health and quality of life. Raising awareness among healthcare professionals and ensuring access to multidisciplinary care are essential steps toward improving outcomes for those living with these conditions. As our understanding of hypermobility disorders evolves, it is imperative that the healthcare system adapts to meet the needs of patients who have long been navigating an arduous path to diagnosis and treatment.
